MIRXES establishes a strategic partnership with N Health
MIRXES-B (02629.HK) announced that on December 15, the company established a strategic partnership with N Health, a member company of Thailand's largest healthcare supplier, aiming to introduce advanced microRNA (miRNA) cancer screening solutions to Thailand. In addition, the company launched a new series of home screening test kits, HELICORapid, in Thailand on January 9, specifically designed for detecting Helicobacter pylori (H. pylori) infections.
The two direct-to-consumer cancer risk factor tests are intended to complement and synergize with the company's core innovative miRNA cancer screening solutions, enabling the company to expand its sales and marketing efforts into the consumer sector
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments